Sciety flags revived US biotech IPO market as 20 listings raise USD 6.1 billion in 2026
Bitget2026/09/28 09:14- Sciety flagged a rebound in US biotech investor appetite, marked by stronger IPO issuance and broad sector gains.
- 20 US drug-development biotech IPOs priced through mid-August 2026, raising about USD 6.1 billion.
- Six Nasdaq biopharma IPOs over the summer upsized, raising USD 1.6 billion.
- Parabilis Medicines raised USD 670 million, described as the largest biotech IPO on record.
- XBI was up more than 80% year-on-year by late August, pointing to improved sentiment.
- Most 2026 IPO issuers were late-stage, with 15 companies at or near Phase 2 or later.
- Europe and the Nordics could see a pickup in biotech demand in H1 2027 if the prior cycle’s lag repeats.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Dow Jones futures slip as Middle East tensions offset Fed rate cut hopes
DBS CIO: Nvidia (NVDA.US) has a forecast P/E ratio of only 17, AI tech stocks are far from bubble territory
The price-to-earnings ratio of NVIDIA (NVDA.US) and its projected 70% earnings growth next year indicate that AI-driven tech stocks are far from entering bubble territory.
Japanese Yen: Broad range holds despite weak momentum against US Dollar – UOB
Hon Hai's revenue in September increased by 38.4% year-on-year, with cumulative growth of nearly 40% in the first three quarters.
On October 5, Foxconn released its financial data, showing sales of TWD 1.16 trillion in September, a year-on-year increase of 38.4%. Third-quarter revenue was approximately TWD 3.027 trillion, up 47% compared to the same period last year, and above analysts’ average expectations of TWD 2.83 trillion. Cumulatively, Foxconn’s revenue for the first nine months of this year reached TWD 7.67 trillion, representing a solid growth of 39.5% compared to the previous year.
Crypto prices
More
